OncoMed Pharmaceuticals
About:
OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer.
Website: http://www.oncomed.com
Top Investors: Adams Street Partners, U.S. Venture Partners, Morgenthaler Ventures, DeNovo Ventures, Bay Partners
Description:
OncoMed Pharmaceuticals is a biotechnology company dedicated to improving cancer treatment, by developing monoclonal antibodies that target the biologic pathways critical to tumor initiating cells, also known as “cancer stem cellsâ€. They are leveraging their understanding of these tumor initiating cells to discover and develop novel therapeutics that could provide important alternatives for the treatment of cancer.
$210M
$10M to $50M
Redwood City, California, United States
2004-08-01
bd(AT)oncomed.com
Max Wicha, Michael F. Clarke
51-100
2013-12-06
Public
© 2025 bioDAO.ai